QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
CVE:THCX

(THCX.V) Competitors

C$5.30
+0.33 (+6.64 %)
(As of 06/21/2018)
Add
Compare
Today's Range
C$5.00
Now: C$5.30
C$5.37
50-Day Range
C$5.30
MA: C$5.30
C$5.30
52-Week Range
C$1.10
Now: C$5.30
C$5.42
Volume5.38 million shs
Average Volume2.35 million shs
Market CapitalizationC$949.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

(THCX.V) (CVE:THCX) Vs. GLH, ACG, HC, BIO, BBM, and LOVE

Should you be buying THCX stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to (THCX.V), including 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), and Cannara Biotech (LOVE).

(THCX.V) (CVE:THCX) and 31444 (CNSX:GLH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and 31444's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
31444N/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and 31444, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
314440000N/A

Profitability

This table compares (THCX.V) and 31444's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
31444N/AN/AN/A

(THCX.V) (CVE:THCX) and 438280 (CNSX:ACG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and 438280's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and 438280, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
4382800000N/A

Profitability

This table compares (THCX.V) and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
438280N/AN/AN/A

(THCX.V) (CVE:THCX) and 815446 (CNSX:HC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and 815446's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
815446N/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and 815446, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
8154460000N/A

Profitability

This table compares (THCX.V) and 815446's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
815446N/AN/AN/A

(THCX.V) (CVE:THCX) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and Bio-Rad Laboratories' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and Bio-Rad Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
Bio-Rad Laboratories0000N/A

Profitability

This table compares (THCX.V) and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

(THCX.V) (CVE:THCX) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and Blueberries Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and Blueberries Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
Blueberries Medical00103.00

Blueberries Medical has a consensus target price of $0.39, suggesting a potential upside of ∞. Given Blueberries Medical's higher probable upside, analysts clearly believe Blueberries Medical is more favorable than (THCX.V).

Profitability

This table compares (THCX.V) and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
Blueberries MedicalN/AN/AN/A

Summary

Blueberries Medical beats (THCX.V) on 2 of the 2 factors compared between the two stocks.

(THCX.V) (CVE:THCX) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Valuation and Earnings

This table compares (THCX.V) and Cannara Biotech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
Cannara BiotechN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (THCX.V) and Cannara Biotech, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
Cannara Biotech0000N/A

Profitability

This table compares (THCX.V) and Cannara Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
Cannara BiotechN/AN/AN/A


(THCX.V) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
1.3N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.